XML 15 R3.htm IDEA: XBRL DOCUMENT v3.20.4
Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenues      
Clinic services $ 1,949,549 $ 1,091,386 $ 1,507,050
Product revenues 82,032 0 0
Total revenues 2,031,581 1,091,386 1,507,050
Direct clinic expenses      
Medical personnel costs 693,150 268,905 456,645
Travel clinic costs 100,224 148,142 182,189
Cost of goods sold 32,902 0 0
Total direct clinic expenses 826,276 417,047 638,834
Earnings from clinic operations 1,205,305 674,339 868,216
Operating expenses 2,933,619 2,517,681 2,037,008
Legal and professional fees 1,015,743 1,450,141 1,131,041
Depreciation and amortization expense 327,059 123,473 103,372
Share-based payments 608,944 892,417 5,433
Loss from operations (3,680,060) (4,309,373) (2,408,638)
Other expenses (income)      
Listing fee 0 1,308,808 0
Accretion expense 114,515 241,521 667,373
Interest expense 240,539 126,375 186,001
Share issuance costs 129,965 0 0
Interest income (4,977) 0 0
Gain on debt settlement or accounts payable (15,130) 0 (106,360)
Gain on termination of leases (76,617) 0 0
Impairment loss on write off of property and equipment 196,252 0 0
Gain on change in fair value of warrant liability (2,065,781) (1,598,425) 0
Gain on change in fair value of conversion feature (587,229) (890,136) 0
Impairment of intangible assets 93,757 64,200 0
Impairment of goodwill 2,377,397 0 0
Impairment of assets held for sale 0 57,072 0
Restructuring expense, net 88,808 110,424 0
Other expense (income), net 130,104 60,706 (45,731)
Other expenses (income) 621,603 (519,455) 701,283
Net loss and comprehensive loss for the year $ (4,301,663) $ (3,789,918) $ (3,109,921)
Loss per share      
Basic $ (0.04) $ (0.06) $ (0.06)
Diluted $ (0.04) $ (0.06) $ (0.06)
Weighted average number of shares outstanding      
Basic 117,289,366 66,670,041 48,072,262
Diluted 117,289,366 66,670,041 48,072,262